These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32441805)

  • 21. Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
    Ghajarzadeh M; Mirmosayyeb O; Barzegar M; Nehzat N; Vaheb S; Shaygannejad V; Maghzi AH
    Mult Scler Relat Disord; 2020 Aug; 43():102222. PubMed ID: 32464586
    [No Abstract]   [Full Text] [Related]  

  • 22. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
    Ferrara F; Granata G; Pelliccia C; La Porta R; Vitiello A
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1615-1618. PubMed ID: 32594204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
    Fragoso-Saavedra S; Iruegas-Nunez DA; Quintero-Villegas A; García-González HB; Nuñez I; Carbajal-Morelos SL; Audelo-Cruz BM; Arias-Martínez S; Caro-Vega Y; Calva JJ; Luqueño-Martínez V; González-Duarte A; Crabtree-Ramírez B; Crispín JC; Sierra-Madero J; Belaunzarán-Zamudio PF; Valdés-Ferrer SI
    BMC Infect Dis; 2020 Oct; 20(1):765. PubMed ID: 33066761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
    Dastan F; Saffaei A; Haseli S; Marjani M; Moniri A; Abtahian Z; Abedini A; Kiani A; Seifi S; Jammati H; Hashemian SMR; Pourabdollah Toutkaboni M; Eslaminejad A; Heshmatnia J; Sadeghi M; Nadji SA; Dastan A; Baghaei P; Varahram M; Yousefian S; Salamzadeh J; Tabarsi P
    Int Immunopharmacol; 2020 Nov; 88():106869. PubMed ID: 32889241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with hospital admission for COVID-19 in HIV patients.
    Di Biagio A; Ricci E; Calza L; Squillace N; Menzaghi B; Rusconi S; Orofino G; Bargiacchi O; Molteni C; Valsecchi L; Cenderello G; Ferrara S; Saracino A; Maggi P; Falasca K; Taramasso L; Bonfanti P;
    AIDS; 2020 Nov; 34(13):1983-1985. PubMed ID: 32796214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
    Hase R; Kurata R; Ishida K; Kurita T; Muranaka E; Mito H
    Intern Med; 2020 Sep; 59(18):2327-2329. PubMed ID: 32727996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept.
    Szabo C; Martins V; Liaudet L
    Am J Respir Cell Mol Biol; 2020 Nov; 63(5):571-590. PubMed ID: 32640172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.
    Kastritis E; Wechalekar A; Schönland S; Sanchorawala V; Merlini G; Palladini G; Minnema M; Roussel M; Jaccard A; Hegenbart U; Kumar S; Cibeira MT; Blade J; Dimopoulos MA
    Br J Haematol; 2020 Aug; 190(3):346-357. PubMed ID: 32480420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 31. Lung Injury in COVID-19-An Emerging Hypothesis.
    Alharthy A; Faqihi F; Memish ZA; Karakitsos D
    ACS Chem Neurosci; 2020 Aug; 11(15):2156-2158. PubMed ID: 32709193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of SARS-CoV-2 pneumonia.
    Sagnelli C; Celia B; Monari C; Cirillo S; De Angelis G; Bianco A; Coppola N
    J Med Virol; 2021 Mar; 93(3):1276-1287. PubMed ID: 32856728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
    Castel AD; Wilbourn B; Magnus M; Greenberg AE
    AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19?
    Páramo JA
    Clin Appl Thromb Hemost; 2020; 26():1076029620933953. PubMed ID: 32697603
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
    Ibáñez S; Martínez O; Valenzuela F; Silva F; Valenzuela O
    Clin Rheumatol; 2020 Aug; 39(8):2461-2465. PubMed ID: 32495226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.
    Dinkin M; Gao V; Kahan J; Bobker S; Simonetto M; Wechsler P; Harpe J; Greer C; Mints G; Salama G; Tsiouris AJ; Leifer D
    Neurology; 2020 Aug; 95(5):221-223. PubMed ID: 32358218
    [No Abstract]   [Full Text] [Related]  

  • 37. Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
    Abobaker A
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1619-1620. PubMed ID: 32607779
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting Proteases for Treating COVID-19.
    Luan B; Huynh T; Cheng X; Lan G; Wang HR
    J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute transverse myelitis after COVID-19 pneumonia.
    Munz M; Wessendorf S; Koretsis G; Tewald F; Baegi R; Krämer S; Geissler M; Reinhard M
    J Neurol; 2020 Aug; 267(8):2196-2197. PubMed ID: 32458198
    [No Abstract]   [Full Text] [Related]  

  • 40. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.
    Crisan-Dabija R; Pavel CA; Popa IV; Tarus A; Burlacu A
    J Proteome Res; 2020 Nov; 19(11):4327-4338. PubMed ID: 32883081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.